Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Asia-Pacific Interventional Cardiology Market Analysis

ID: MRFR//0682-HCR | 80 Pages | Author: Kinjoll Dey| May 2024

There are a lot more heart diseases and older people living in the Asia-Pacific area. This may be what is causing the interventional cardiology market to grow so quickly. Because of this, there is a greater need for tools and treatments in invasive cardiology.
Invasive cardiology techniques and approaches have changed significantly in recent months. New imaging, drug-eluting, and bioresorbable stents are improving therapy accuracy and efficacy. This boosts the market.
Asia and the Pacific are witnessing more coronary artery disease and myocardial ischemia. Globally, more individuals are developing these diseases. Due to lifestyle, diet, and exercise changes, more individuals are suffering heart disease. Thus, invasive cardiac options are essential.
Several Asia-Pacific nations are improving health care and other measures to combat growing heart disease rates. Money spent on facilities and programs to teach interventional cardiology is making it simpler to acquire treatments. This improves corporate operations.
Asia and the Pacific are spending more on healthcare. This makes invasive cardiac therapies more complicated. More individuals are insured and willing to pay on health care. Both of these things are making the market grow.
The biggest companies in Asia and the Pacific are now teaming up with other businesses to make agreements and partnerships that work well. This is done to improve their product lines and market positions. Health care providers, medical equipment makers, and study places that work together bring about new ideas and make the market more competitive.
Today, the Asia-Pacific interventional cardiology market is having trouble, even though the future looks bright. This is because of problems with payment, rules and laws, and the high cost of new technologies. This needs to be fixed right away so that the market keeps growing and more people can get invasive heart treatments.
More and more, methods that do less harm are being used in the field of invasive cardiology. This is because these methods work better and faster, and there is less chance of problems. The market is changing because more and more patients and doctors are picking less invasive methods.
Invasive cardiology market leaders in Asia-Pacific compete for market share. Companies are creating new goods, partnering with others, and expanding to remain ahead of the competition. Competition is driving innovation and market shifts.
It looks like the Asia-Pacific interventional cardiology market will do well in the future because companies will keep working together, doing research and development, and making technology progress. As people in the area try to get the health care they need, the market is likely to keep growing. This means that both well-known companies in the field of invasive cardiology and new companies that want to get into the market will have chances to do well.

Asia Pacific Interventional Cardiology Market Scenario:

Asia pacific interventional cardiology market is anticipated to reach USD 2.8 Million by 2032 at 8% CAGR during the forecast period 2023-2032

Interventional cardiology is a branch of cardiology that deals with catheter based treatment for heart diseases. By catheterization, number of procedures can be performed on the heart. According to International Diabetes Federation, 60% of world’s total diabetic population lives in Asia. Diabetic is one of the major factors which lead to cardiovascular diseases. Increasing prevalence of cardiovascular diseases is the major factor for the growth of the market in Asia Pacific. Beside this increasing incidences of diabetes and obesity, change in lifestyle, increasing awareness among the people and rapid development in technology also contributed to the growth of the market. On other hand, high cost for manufacturing the devices and lot of barriers for the development of the new device are the major restraints hampering the market growth.

Figure 1- Asia Pacific interventional cardiology market, by application

 Asia Pacific interventional cardiology market

Sources- Annual reports, White paper, Company Presentation


Asia Pacific interventional cardiology market is segmented on the basis of type, into catheters, stents, balloons, vascular closure devices, laser procedures, atherectomy and other. Stents are sub segmented into metal stents, drug eluting stents and bioresorbable stents. Balloons are further segmented into cutting balloons, drug eluting balloons and other. On the basis of end users the Asia Pacific interventional cardiology market is segmented into catheterization laboratories, hospitals and clinics and others

Regional Analysis:

On the basis of region, Asia Pacific interventional cardiology market is segmented into countries namely Japan, India, China, Australia, Republic of Korea and Rest of Asia Pacific. China accounts for the largest market share which is attributed to an increase in incidence of chronic heart diseases, increasing geriatric population, and demand for early diagnosis of cardiac disease. India holds the second largest market whereas Japan shows steady growth in this market.

Key Players for Asia Pacific interventional cardiology market

Abbott Laboratories Inc. (U.S.), B. Braun Melsungen AG (Germany), C.R. Bard, Inc. (U.S.), Abiomed Inc. (U.S), Edwards Lifesciences (U.S.), Biosensors International Group, Ltd. ( Singapore), Boston Scientific Corporation (U.S.), Medtronic PLC (Ireland), Angiodynamics, Inc. ( U.S), Terumo Medical Corporation (Japan), Johnson & Johnson Services, Inc. (U.S.)., Lombard Medical Technologies, Plc. (U.K), Clearstream Technologies Group Plc. (Ireland).

Study objectives Asia Pacific interventional cardiology market

  • Detailed information about the factors affecting the growth of the Asia Pacific interventional cardiology

  • Detailed analysis of parent market with respect to all the possible segmentation of the market.

  • Detailed analysis of emerging key players for the market with their effective strategies.

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Asia Pacific interventional cardiology market.

  • Analysis of the market of the different factors like- Price Analysis, Supply Chain Analysis, Porters’ Five Force Analysis etc.

  • Detailed information on the possible segments and sub segments of the market and its regional analysis.

  • Insights on the major countries in which this industry is blooming and to also identify the regions that are still untapped

  • Detailed information on trends and the opportunities in various regions

Intended Audience

  • Research and Development (R&D) Companies

  • Catheter manufacturing company

  • Government and Independent Research Laboratories

  • Government and Independent Regulatory Authorities

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities

The report for Asia Pacific interventional cardiology market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.